NINE MONTHS RESULTS
Dr. Reddy's Laboratories Ltd.
BSE
Apr 30
1183.00
+6.75 (+ 0.57%)
Volume
44575
Prev. Close
1176.25
Open Price
1176.25
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
1183.90
+7.90 (+ 0.67%)
Volume
1604442
Prev. Close
1176.00
Open Price
1176.20
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Nine Months Results
for the last 5 years.
|
ISIN No
|
INE089A01031
|
Market Cap. ( ₹ in Cr. )
|
98791.17
|
P/BV
|
3.21
|
Book Value ( ₹ )
|
368.50
|
|
BSE Code
|
500124
|
52 Week High/Low ( ₹ )
|
1421/1020
|
FV/ML
|
1/1
|
P/E(X)
|
17.71
|
|
NSE Code
|
DRREDDYEQ
|
Book Closure
|
28/10/2024
|
EPS ( ₹ )
|
66.84
|
Div Yield (%)
|
0.68
|
(₹ in Crs.)
| Net Sales/Income from operations | 17552.50 | 14379.00 | 12408.50 | 10736.50 | 9998.40 |
| Total Income From Operations | 17552.50 | 14379.00 | 12408.50 | 10736.50 | 9998.40 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 2857.10 | 2383.80 | 2307.30 | 2051.70 | 2450.00 |
| Purchase of Traded Goods | 1905.20 | 1440.30 | 1410.10 | 2033.50 | 925.70 |
| Increase/Decrease in Stocks | -256.10 | -186.80 | 22.70 | -333.90 | -416.40 |
| Employees Cost | 2490.40 | 2306.20 | 2067.50 | 1825.70 | 1724.50 |
| Depreciation | 774.90 | 729.40 | 686.50 | 609.10 | 624.30 |
| Other Expenses | 4656.80 | 3903.20 | 3505.00 | 3235.30 | 2780.70 |
| Total Expenses | 12428.30 | 10576.10 | 9999.10 | 9421.40 | 8088.80 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 5124.20 | 3802.90 | 2409.40 | 1315.10 | 1909.60 |
| Other Income | 628.70 | 665.10 | 534.30 | 367.30 | 719.50 |
| P/L Before Interest, Excpt. Items & Tax | 5752.90 | 4468.00 | 2943.70 | 1682.40 | 2629.10 |
| Interest | 78.80 | 15.90 | 14.30 | 25.30 | 29.80 |
| P/L Before Exceptional Items & Tax | 5674.10 | 4452.10 | 2929.40 | 1657.10 | 2599.30 |
| P/L Before Tax | 5674.10 | 4452.10 | 2929.40 | 1657.10 | 2599.30 |
| Tax | 1525.40 | 1144.90 | 989.00 | 453.60 | 724.40 |
| P/L After Tax from Ordinary Activities | 4148.70 | 3307.20 | 1940.40 | 1203.50 | 1874.90 |
| Net Profit/Loss For the Period | 4148.70 | 3307.20 | 1940.40 | 1203.50 | 1874.90 |
| | | | | | |
| Equity Share Capital | 83.40 | 83.40 | 83.30 | 83.20 | 83.10 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 49.81 | 198.81 | 116.88 | 72.56 | 113.05 |
| Diluted EPS (Rs.) | 49.73 | 198.43 | 116.63 | 72.38 | 112.73 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 49.81 | 198.81 | 116.88 | 72.56 | 113.05 |
| Diluted EPS (Rs.) | 49.73 | 198.43 | 116.63 | 72.38 | 112.73 |
| | | | | | |
| PBITOE Margin (%) | 29.19 | 26.44 | 19.41 | 12.24 | 19.09 |
| PBTE Margin (%) | 32.32 | 30.96 | 23.60 | 15.43 | 25.99 |
| PBT Margin (%) | 32.32 | 30.96 | 23.60 | 15.43 | 25.99 |
| PAT Margin (%) | 23.63 | 23.00 | 15.63 | 11.20 | 18.75 |